A carregar...
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
SIMPLE SUMMARY: In 2021, the identification of effective biomarkers became a major focus of prostate cancer (PCa) in order to improve outcomes and select potentially responsive patients. The aim of this contribution is to review the main 2021 novelties in prognostic and therapeutic markers in PCa, w...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8307279/ https://ncbi.nlm.nih.gov/pubmed/34298683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143471 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|